These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Choice of a progestagen in ovulatory dysfunction]. Bruhat MA Ann Endocrinol (Paris); 1979; 40(3 Suppl):362-6. PubMed ID: 496383 [No Abstract] [Full Text] [Related]
3. [Neuroendocrine disorders in epilepsy and their hormonal correction]. Badalian LO; Temin PA; Mukhin Kiu ; Semenov PA Sov Med; 1989; (10):49-51. PubMed ID: 2694382 [No Abstract] [Full Text] [Related]
4. [New preparations for treatment of climacterial disorders]. Nesheim BI Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446 [TBL] [Abstract][Full Text] [Related]
5. [Oral hormone therapy in the pre- and postmenopausal period]. Braendle W; Bettendorf G Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595 [No Abstract] [Full Text] [Related]
6. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
8. Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy. Riis B; Christiansen C Med Klin (Munich); 1987 Mar; 82(6):238-41. PubMed ID: 3587168 [No Abstract] [Full Text] [Related]
9. [New viewpoints in the treatment of postmenopausal complaints]. Lauritzen C Arch Gynecol Obstet; 1987; 242(1-4):471-9. PubMed ID: 3688962 [No Abstract] [Full Text] [Related]
10. [General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra]. Ziegler R Med Klin (Munich); 1987 Mar; 82(6):241-4. PubMed ID: 3587169 [No Abstract] [Full Text] [Related]
11. [Management of the disordered ovarian function: sex steroids]. Taubert HD Gynakol Rundsch; 1978; 18(2):101-15. PubMed ID: 566242 [No Abstract] [Full Text] [Related]
12. [Use of combined steroid preparations for the treatment of juvenile hemorrhages]. Kuznetsova MN; Antipina NN Akush Ginekol (Mosk); 1979 Oct; (10):59-60. PubMed ID: 507344 [No Abstract] [Full Text] [Related]
13. Estrogen use and cardiovascular disease. Henderson BE; Ross RK; Paganini-Hill A J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and therapeutic problems in gonadal dysgenesis]. Bolis PF; Ravagni Probizer MF; Mandelli B; Franchi M Ann Ostet Ginecol Med Perinat; 1982; 103(3):230-6. PubMed ID: 6753694 [No Abstract] [Full Text] [Related]
15. [Incidence and treatment of dysfunctional metrorrhagias of puberty]. Dalla Pria S; Ambrosini A; D'Antona N Minerva Ginecol; 1976 Jun; 28(6):491-4. PubMed ID: 1018832 [No Abstract] [Full Text] [Related]
16. [Drug therapy of endometriosis]. Dalla Pria S; Ambrosini A; D'Antona N Minerva Ginecol; 1976 Jun; 28(6):499-501. PubMed ID: 1018834 [No Abstract] [Full Text] [Related]
17. [Results of treatment of patients with dysfunctional uterine hemorrhages with different types of synthetic progestins]. Sotnikova EI Sov Med; 1975 Jun; (6):31-5. PubMed ID: 1162470 [No Abstract] [Full Text] [Related]
18. Open forum: Diagnosis and treatment of endometriosis. Int J Fertil; 1984; 29(1):1-9. PubMed ID: 6146575 [No Abstract] [Full Text] [Related]
19. [Treatment of juvenile uterine hemorrhages with synthetic progestins]. Antipina NN Vopr Okhr Materin Det; 1975 Jul; 20(7):70-3. PubMed ID: 1220184 [No Abstract] [Full Text] [Related]
20. [Oxyprogesterone capronate in the treatment of menstrual epilepsy]. Badalian LO; Temin PA; Mukhin KIu Ross Med Zh; 1992; (3):41-4. PubMed ID: 1643360 [No Abstract] [Full Text] [Related] [Next] [New Search]